Profil
John George Anson is currently the Chief Executive Officer & Director at Oxford Gene Technology Ltd. He is also a Director at Oxford Gene Technology IP Ltd. and Oxford Gene Technology (Operations) Ltd. Previously, he held positions as a Director at Cytocell Ltd., Vice President & Head-Product Development at PharmaGenics, Inc., Vice President-Business Development at GE Healthcare Ltd. (United Kingdom), and Vice President-Business Development at Global Life Sciences Solutions USA LLC.
Dr. Anson holds a doctorate degree from Cranfield University and an undergraduate degree from the University of Kent.
Postes actifs de John George Anson
| Sociétés | Poste | Début |
|---|---|---|
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Develops arrays used in genomics research | Directeur Général | 10/04/2018 |
Oxford Gene Technology IP Ltd.
Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Directeur/Membre du Conseil | - |
Oxford Gene Technology (Operations) Ltd.
Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops, manufactures and markets molecular genetics | Directeur/Membre du Conseil | 23/02/2018 |
Anciens postes connus de John George Anson
| Sociétés | Poste | Fin |
|---|---|---|
Cytocell Ltd.
Cytocell Ltd. Medical SpecialtiesHealth Technology Develops medical diagnostic solutions and services | Directeur/Membre du Conseil | - |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Corporate Officer/Principal | - |
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products for cancer | Corporate Officer/Principal | - |
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Manufactures therapeutics | Corporate Officer/Principal | - |
Formation de John George Anson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Develops arrays used in genomics research | Commercial Services |
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products for cancer | Commercial Services |
Cytocell Ltd.
Cytocell Ltd. Medical SpecialtiesHealth Technology Develops medical diagnostic solutions and services | Health Technology |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
Cranfield University
Cranfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kent
University of Kent Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Manufactures therapeutics | Health Technology |
Oxford Gene Technology IP Ltd.
Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Oxford Gene Technology (Operations) Ltd.
Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops, manufactures and markets molecular genetics | Health Technology |
















